Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061297) titled 'Skeletal muscle-based treatment strategies for immune checkpoint inhibitor' on June 1.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - Urothelial carcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - We investigated patients with urothelial carcinoma receiving treatment with immune checkpoint inhibitors, focusing on: (1) body composition related to sarcopenia (such as skeletal muscle mass, muscle strength, and muscle quality), (2) skeletal muscle-related factors involved in immune regulat...